Rgenta Therapeutics, Inc.
New Filing
CIK: 0001801266·Other Technology·DELAWARE·Filed: Nov 3, 2026
Total Offering
$130,107,279
Amount Sold
$41,852,307
Investors
9
First Sale
Oct 19, 2026
Offering Details
- Type
- Equity, Debt
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Hualin Simon Xi | Related Person |
| Yichao Fan | Related Person |
| Debasish Roychowdhury | Related Person |
| Julia Kaufman | Related Person |
| Sean Zhang | Related Person |
| Cillian King | Related Person |
| James Kasuboski | Related Person |
| Travis Wager | Related Person |
| Weng Zhiping | Related Person |
| Jeff Guckert | Related Person |
Company
SEC Filing
0001231919-26-001529
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free